374 related articles for article (PubMed ID: 12771010)
21. Right isthmus ablation reduces supraventricular arrhythmias after surgery for chronic atrial fibrillation.
Onorati F; Esposito A; Messina G; di Virgilio A; Renzulli A
Ann Thorac Surg; 2008 Jan; 85(1):39-48. PubMed ID: 18154775
[TBL] [Abstract][Full Text] [Related]
22. [Cost effectiveness of ACE inhibition in therapy of chronic heart failure in Switzerland: evaluation based on the SOLVD study].
Szucs TD; Goedde M; Berger K; Kiowski W
Schweiz Med Wochenschr; 1997 Jul; 127(29-30):1234-41. PubMed ID: 9333933
[TBL] [Abstract][Full Text] [Related]
23. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
Saha SA; Molnar J; Arora RR
Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
[TBL] [Abstract][Full Text] [Related]
24. Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD).
Vermes E; Ducharme A; Bourassa MG; Lessard M; White M; Tardif JC;
Circulation; 2003 Mar; 107(9):1291-6. PubMed ID: 12628950
[TBL] [Abstract][Full Text] [Related]
25. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
O'Meara E; Khairy P; Blanchet MC; de Denus S; Pedersen OD; Levesque S; Talajic M; Ducharme A; White M; Racine N; Rouleau JL; Tardif JC; Roy D;
Circ Heart Fail; 2012 Sep; 5(5):586-93. PubMed ID: 22798522
[TBL] [Abstract][Full Text] [Related]
26. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
Haywood LJ; Ford CE; Crow RS; Davis BR; Massie BM; Einhorn PT; Williard A;
J Am Coll Cardiol; 2009 Nov; 54(22):2023-31. PubMed ID: 19926008
[TBL] [Abstract][Full Text] [Related]
27. Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience.
Lehto M; Snapinn S; Dickstein K; Swedberg K; Nieminen MS;
Eur Heart J; 2005 Feb; 26(4):350-6. PubMed ID: 15618041
[TBL] [Abstract][Full Text] [Related]
28. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
Flaker GC; Belew K; Beckman K; Vidaillet H; Kron J; Safford R; Mickel M; Barrell P;
Am Heart J; 2005 Apr; 149(4):657-63. PubMed ID: 15990749
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of gemfibrozil in the primary prevention of atrial fibrillation in a large randomized controlled trial.
Adabag AS; Mithani S; Al Aloul B; Collins D; Bertog S; Bloomfield HE;
Am Heart J; 2009 May; 157(5):913-8. PubMed ID: 19376321
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation.
L'Allier PL; Ducharme A; Keller PF; Yu H; Guertin MC; Tardif JC
J Am Coll Cardiol; 2004 Jul; 44(1):159-64. PubMed ID: 15234426
[TBL] [Abstract][Full Text] [Related]
31. The long-term impact of the angiotensin-converting enzyme inhibitor trandolapril on mortality and hospital admissions in patients with left ventricular dysfunction after a myocardial infarction: follow-up to 12 years.
Buch P; Rasmussen S; Abildstrom SZ; Køber L; Carlsen J; Torp-Pedersen C;
Eur Heart J; 2005 Jan; 26(2):145-52. PubMed ID: 15618070
[TBL] [Abstract][Full Text] [Related]
32. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG
Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817
[TBL] [Abstract][Full Text] [Related]
34. Early versus delayed enalapril in patients with left ventricular systolic dysfunction: impact on morbidity and mortality 15 years after the SOLVD trial.
Ahn SA; Jong P; Yusuf S; Bangdiwala SI; Pouleur HG; Rousseau MF
J Am Coll Cardiol; 2006 May; 47(9):1904-5. PubMed ID: 16682319
[No Abstract] [Full Text] [Related]
35. Coronary surgery in patients with preexisting chronic atrial fibrillation: early and midterm clinical outcome.
Rogers CA; Angelini GD; Culliford LA; Capoun R; Ascione R
Ann Thorac Surg; 2006 May; 81(5):1676-82. PubMed ID: 16631655
[TBL] [Abstract][Full Text] [Related]
36. Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction.
Murcia AM; Hennekens CH; Lamas GA; Jiménez-Navarro M; Rouleau JL; Flaker GC; Goldman S; Skali H; Braunwald E; Pfeffer MA
Arch Intern Med; 2004 Nov; 164(20):2273-9. PubMed ID: 15534166
[TBL] [Abstract][Full Text] [Related]
37. Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects in patients with predominantly left ventricular dysfunction and heart failure.
Böhm M; Pogue J; Kindermann I; Pöss J; Koon T; Yusuf S
Eur J Heart Fail; 2014 Mar; 16(3):325-33. PubMed ID: 24464788
[TBL] [Abstract][Full Text] [Related]
38. Consequence of atrial fibrillation and the risk of embolism after percutaneous mitral commissurotomy: the necessity of the maze procedure.
Nakajima H; Kobayashi J; Bando K; Yasumura Y; Nakatani S; Kimura K; Niwaya K; Tagusari O; Kitamura S
Ann Thorac Surg; 2004 Sep; 78(3):800-5; discussion 805-6. PubMed ID: 15336994
[TBL] [Abstract][Full Text] [Related]
39. Inefficiency of renin-angiotensin inhibitors in preventing atrial fibrillation in patients with a normal heart.
Fazio G; Pizzuto C; Sutera L; Guttilla D; Di Gesaro G; Cascio C; Novo G; Assennato P; Novo S
Minerva Cardioangiol; 2007 Jun; 55(3):311-5. PubMed ID: 17534249
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and prognostic significance of atrial fibrillation in outpatients with heart failure due to left ventricular systolic dysfunction.
Corell P; Gustafsson F; Schou M; Markenvard J; Nielsen T; Hildebrandt P
Eur J Heart Fail; 2007 Mar; 9(3):258-65. PubMed ID: 17027330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
